India’s pharmaceutical sector projected to reach $130 billion by 2030
India is on the cusp of a transformative era in its pharmaceutical sector which is projected to reach $130 billion by 2030, a report showed on Thursday.
India is on the cusp of a transformative era in its pharmaceutical sector which is projected to reach $130 billion by 2030, a report showed on Thursday.
A high-profile delegation from India consisting of representatives from various sectors is currently attending a conference showcasing the trade potential between India and Vietnam.
The medical concept of care and cure appears to have been binned with the detection of anti-diabetic, anti-epileptic, and pain-relieving drugs in river water in Delhi and Hyderabad, thus making a mockery of the prognosis of an ailment. The canker is palpable no less in Iceland, Venezuela, New York, London, Glasgow, Bolivia, Ethiopia, and Lahore.
India has a disappointing health and safety record. Much legislation exists to protect workers' rights and health, but there is an opportunity to improve in line with the approach taken by developed countries and include process safety elements for the prevention of accidents.
Opportunities in the pharmaceutical sector are not only quite high but also growing at an exponential rate
Though India produces 20% of the world’s generic drug supply, pharma companies in the country are dependent on China for two-thirds of the chemical components needed to make them.
